Dave Allsop

Dave Allsop is a Scottish game designer and artist for role-playing games and video games. Provided by Wikipedia
Showing 1 - 11 results of 11 for search 'David Allsop', query time: 0.04s Refine Results
  1. 1
    Variation in the concentration and regional distribution of magnetic nanoparticles in human brains, with and without Alzheimer’s disease, from the UK

    Variation in the concentration and regional distribution of magnetic nanoparticles in human brains, with and without Alzheimer’s disease, from the UK by Jessica Hammond, Barbara A. Maher, Imad A. M. Ahmed, David Allsop

    Published 2021-04-01
    Get full text
    Article
  2. 2
    Oxidative Stress, Cytotoxic and Inflammatory Effects of Urban Ultrafine Road-Deposited Dust from the UK and Mexico in Human Epithelial Lung (Calu-3) Cells

    Oxidative Stress, Cytotoxic and Inflammatory Effects of Urban Ultrafine Road-Deposited Dust from the UK and Mexico in Human Epithelial Lung (Calu-3) Cells by Jessica Hammond, Barbara A. Maher, Tomasz Gonet, Francisco Bautista, David Allsop

    Published 2022-09-01
    Get full text
    Article
  3. 3
    Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome

    Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syn... by Harutsugu Tatebe, Takashi Kasai, Takuma Ohmichi, Yusuke Kishi, Tomoshi Kakeya, Masaaki Waragai, Masaki Kondo, David Allsop, Takahiko Tokuda

    Published 2017-09-01
    Get full text
    Article
  4. 4
    Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer’s disease

    Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer’s disease by Makiko Shinomoto, Takashi Kasai, Harutsugu Tatebe, Fukiko Kitani-Morii, Takuma Ohmichi, Yuzo Fujino, David Allsop, Toshiki Mizuno, Takahiko Tokuda

    Published 2021-01-01
    Get full text
    Article
  5. 5
    Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients.

    Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients. by Makiko Shinomoto, Takashi Kasai, Harutsugu Tatebe, Masaki Kondo, Takuma Ohmichi, Masafumi Morimoto, Tomohiro Chiyonobu, Naoto Terada, David Allsop, Isao Yokota, Toshiki Mizuno, Takahiko Tokuda

    Published 2019-01-01
    Get full text
    Article
  6. 6
    A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.

    A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease. by Vadivel Parthsarathy, Paula L McClean, Christian Hölscher, Mark Taylor, Claire Tinker, Glynn Jones, Oleg Kolosov, Elisa Salvati, Maria Gregori, Massimo Masserini, David Allsop

    Published 2013-01-01
    Get full text
    Article
  7. 7
    Correction: A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease.

    Correction: A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer... by Vadivel Parthsarathy, Paula L. McClean, Christian Hölscher, Mark Taylor, Claire Tinker, Glynn Jones, Oleg Kolosov, Elisa Salvati, Maria Gregori, Massimo Masserini, David Allsop

    Published 2013-01-01
    Get full text
    Article
  8. 8
    Combined use of CSF NfL and CSF TDP‐43 improves diagnostic performance in ALS

    Combined use of CSF NfL and CSF TDP‐43 improves diagnostic performance in ALS by Takashi Kasai, Yuta Kojima, Takuma Ohmichi, Harutsugu Tatebe, Yukiko Tsuji, Yu‐ichi Noto, Fukiko Kitani‐Morii, Makiko Shinomoto, David Allsop, Toshiki Mizuno, Takahiko Tokuda

    Published 2019-12-01
    Get full text
    Article
  9. 9
    Alzheimer's disease diagnosis by blood plasma molecular fluorescence spectroscopy (EEM)

    Alzheimer's disease diagnosis by blood plasma molecular fluorescence spectroscopy (EEM) by Ricardo Fernandes dos Santos, Maria Paraskevaidi, David M. A. Mann, David Allsop, Marfran C. D. Santos, Camilo L. M. Morais, Kássio M. G. Lima

    Published 2022-09-01
    Get full text
    Article
  10. 10
    Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease.

    Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease. by Takashi Kasai, Masaki Kondo, Ryotaro Ishii, Akihiro Tanaka, Suzuka Ataka, Hiroyuki Shimada, Takami Tomiyama, Hiroshi Mori, Mark Taylor, David Allsop, Masanori Nakagawa, Toshiki Mizuno, Takahiko Tokuda

    Published 2017-01-01
    Get full text
    Article
  11. 11
    Increased levels of plasma total tau in adult Down syndrome.

    Increased levels of plasma total tau in adult Down syndrome. by Takashi Kasai, Harutsugu Tatebe, Masaki Kondo, Ryotaro Ishii, Takuma Ohmichi, Wing Tung Esther Yeung, Masafumi Morimoto, Tomohiro Chiyonobu, Naoto Terada, David Allsop, Masanori Nakagawa, Toshiki Mizuno, Takahiko Tokuda

    Published 2017-01-01
    Get full text
    Article

Search Tools: